TY - JOUR
T1 - Paroxysmal slow cortical activity in Alzheimer’s disease and epilepsy is associated with blood-brain barrier dysfunction
AU - Milikovsky, Dan Z.
AU - Ofer, Jonathan
AU - Senatorov, Vladimir V.
AU - Friedman, Aaron R.
AU - Prager, Ofer
AU - Sheintuch, Liron
AU - Elazari, Netta
AU - Veksler, Ronel
AU - Zelig, Daniel
AU - Weissberg, Itai
AU - Bar-Klein, Guy
AU - Swissa, Evyatar
AU - Hanael, Erez
AU - Ben-Arie, Gal
AU - Schefenbauer, Osnat
AU - Kamintsky, Lyna
AU - Saar-Ashkenazy, Rotem
AU - Shelef, Ilan
AU - Shamir, Merav H.
AU - Goldberg, Ilan
AU - Glik, Amir
AU - Benninger, Felix
AU - Kaufer, Daniela
AU - Friedman, Alon
N1 - Publisher Copyright:
Copyright © 2019 The Authors,
PY - 2019/12/4
Y1 - 2019/12/4
N2 - A growing body of evidence shows that epileptic activity is frequent but often undiagnosed in patients with Alzheimer’s disease (AD) and has major therapeutic implications. Here, we analyzed electroencephalogram (EEG) data from patients with AD and found an EEG signature of transient slowing of the cortical network that we termed paroxysmal slow wave events (PSWEs). The occurrence per minute of the PSWEs was correlated with level of cognitive impairment. Interictal (between seizures) PSWEs were also found in patients with epilepsy, localized to cortical regions displaying blood-brain barrier (BBB) dysfunction, and in three rodent models with BBB pathology: aged mice, young 5x familial AD model, and status epilepticus–induced epilepsy in young rats. To investigate the potential causative role of BBB dysfunction in network modifications underlying PSWEs, we infused the serum protein albumin directly into the cerebral ventricles of naïve young rats. Infusion of albumin, but not artificial cerebrospinal fluid control, resulted in high incidence of PSWEs. Our results identify PSWEs as an EEG manifestation of nonconvulsive seizures in patients with AD and suggest BBB pathology as an underlying mechanism and as a promising therapeutic target.
AB - A growing body of evidence shows that epileptic activity is frequent but often undiagnosed in patients with Alzheimer’s disease (AD) and has major therapeutic implications. Here, we analyzed electroencephalogram (EEG) data from patients with AD and found an EEG signature of transient slowing of the cortical network that we termed paroxysmal slow wave events (PSWEs). The occurrence per minute of the PSWEs was correlated with level of cognitive impairment. Interictal (between seizures) PSWEs were also found in patients with epilepsy, localized to cortical regions displaying blood-brain barrier (BBB) dysfunction, and in three rodent models with BBB pathology: aged mice, young 5x familial AD model, and status epilepticus–induced epilepsy in young rats. To investigate the potential causative role of BBB dysfunction in network modifications underlying PSWEs, we infused the serum protein albumin directly into the cerebral ventricles of naïve young rats. Infusion of albumin, but not artificial cerebrospinal fluid control, resulted in high incidence of PSWEs. Our results identify PSWEs as an EEG manifestation of nonconvulsive seizures in patients with AD and suggest BBB pathology as an underlying mechanism and as a promising therapeutic target.
UR - http://www.scopus.com/inward/record.url?scp=85076088676&partnerID=8YFLogxK
U2 - 10.1126/scitranslmed.aaw8954
DO - 10.1126/scitranslmed.aaw8954
M3 - Article
C2 - 31801888
AN - SCOPUS:85076088676
SN - 1946-6234
VL - 11
JO - Science Translational Medicine
JF - Science Translational Medicine
IS - 521
M1 - eaaw8954
ER -